{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T14:38:16Z","timestamp":1787323096816,"version":"build-2736575974"},"reference-count":12,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"Abstract<\/jats:title>\n \n Purpose<\/jats:title>\n Sequential nephron blockade is commonly used to augment diuresis in patients with volume overload receiving loop diuretics. While metolazone is frequently used, acetazolamide has emerged as an alternative adjunctive agent. Real-world data comparing these strategies remain limited. This study evaluated the effectiveness and safety of acetazolamide vs metolazone as adjunctive therapy.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n This single-center, retrospective cohort study included adult patients receiving adjunctive acetazolamide or metolazone with loop diuretics for volume overload. The primary outcome was cumulative urine output within 48\u2005hours. Secondary outcomes included high diuretic response (urine output above the cohort median), hypotension, acute kidney injury, hypokalemia, and metabolic acidosis. Multivariable regression and propensity score\u2013matched analyses were performed.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n A total of 120 patients were included (metolazone, n = 70; acetazolamide, n = 50). Patients receiving metolazone were older and had higher baseline serum creatinine levels. Mean (SD) cumulative urine output was greater with acetazolamide (10,637 [13,847] vs 5,752 [10,231] mL; P = 0.028). After adjustment, acetazolamide remained associated with greater urine output (\u03b2 = 4,735\u2005mL; 95% confidence interval [CI], 39-9,430\u2005mL; P = 0.048). High diuretic response occurred more frequently with acetazolamide (64% vs 40%), with higher adjusted odds (odds ratio, 3.18; 95% CI, 1.40-7.47; P = 0.0065). Findings were consistent in propensity score\u2013matched analyses. Adverse event rates were similar between the groups.<\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n Adjunctive acetazolamide was associated with greater urine output and a higher likelihood of achieving a robust diuretic response compared with metolazone. Given the retrospective study design, these findings are hypothesis generating and warrant confirmation in prospective comparative studies.<\/jats:p>\n <\/jats:sec>","DOI":"10.1093\/ajhp\/zxag236","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T11:52:16Z","timestamp":1786189936000},"source":"Crossref","is-referenced-by-count":0,"title":["Acetazolamide versus metolazone as adjunctive therapy to loop diuretics in hospitalized patients with volume overload: A retrospective cohort study"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4201-9349","authenticated-orcid":false,"given":"Phuoc (Tyler)","family":"Bui","sequence":"first","affiliation":[{"name":"University of Florida College of Pharmacy , Orlando, FL"},{"name":"Critical Care, AdventHealth Celebration , Celebration, FL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizbeth","family":"Ramos","sequence":"additional","affiliation":[{"name":"AdventHealth Celebration , Celebration, FL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"issue":"18","key":"2026082109414263900_zxag236-B1","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"issue":"20","key":"2026082109414263900_zxag236-B2","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1056\/NEJMra1703100","article-title":"Diuretic treatment in heart failure","volume":"377","author":"Ellison","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"2026082109414263900_zxag236-B3","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1053\/j.ajkd.2016.08.027","article-title":"Diuretic resistance","volume":"69","author":"Hoorn","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"2026082109414263900_zxag236-B4","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"2026082109414263900_zxag236-B5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11897-019-0424-1","article-title":"Loop diuretic resistance in heart failure","volume":"16","author":"Cox","year":"2019","journal-title":"Curr Heart Fail Rep"},{"issue":"6","key":"2026082109414263900_zxag236-B6","first-page":"581","article-title":"Diuretic resistance: physiology and therapeutics","volume":"19","author":"Ellison","year":"1999","journal-title":"Semin Nephrol"},{"key":"2026082109414263900_zxag236-B7","first-page":"1601","article-title":"Abnormal renal sodium handling in heart failure","volume":"34","author":"Verbrugge","year":"2013","journal-title":"Eur Heart J"},{"issue":"1","key":"2026082109414263900_zxag236-B8","doi-asserted-by":"crossref","first-page":"e002370","DOI":"10.1161\/CIRCHEARTFAILURE.115.002370","article-title":"Rapid and highly accurate prediction of poor loop diuretic natriuretic response in patients with heart failure","volume":"9","author":"Testani","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"1","key":"2026082109414263900_zxag236-B9","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0002-9343(98)00365-9","article-title":"Diuretic treatment and diuretic resistance in heart failure","volume":"106","author":"Kramer","year":"1999","journal-title":"Am J Med"},{"issue":"6","key":"2026082109414263900_zxag236-B10","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1056\/NEJMra1503102","article-title":"Diuretics and potassium balance","volume":"373","author":"Palmer","year":"2015","journal-title":"N Engl J Med"},{"issue":"13","key":"2026082109414263900_zxag236-B11","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJMoa2203094","article-title":"Acetazolamide in acute decompensated heart failure with volume overload","volume":"387","author":"Mullens","year":"2022","journal-title":"N Engl J Med"},{"issue":"6","key":"2026082109414263900_zxag236-B12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJM199808063390607","article-title":"Diuretic therapy","volume":"339","author":"Brater","year":"1998","journal-title":"N Engl J Med"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxag236\/70608681\/zxag236.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxag236\/70608681\/zxag236.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:41:48Z","timestamp":1787319708000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article\/doi\/10.1093\/ajhp\/zxag236\/8758813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":12,"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxag236","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"article-number":"zxag236"}}